• FirefoxTry Yahoo Finance on Firefox »
  •  Dow up 0.58% Nasdaq up 0.47%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow up 0.58% Nasdaq up 0.47%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    04:00pm EST 23.11 -0.01 -0.04% 22.94 23.49 3,934,172 5,541,500 6.62B Sparkline Chart Chart, News, Stats, Options, Board
    04:02pm EST 11.50 +0.25 +2.22% 11.25 11.65 265,880 387,243 1.04B Sparkline Chart Chart, News, Stats, Options, Board
    04:00pm EST 14.90 -0.37 -2.42% 14.73 15.69 256,603 267,610 434.11M Sparkline Chart Chart, News, Stats, Options, Board
    04:00pm EST 16.05 -2.95 -15.53% 14.70 16.65 4,435,598 676,364 1.14B Sparkline Chart Chart, News, Stats, Options, Board
    {"s" : "exel,rate,nlnk,mnta","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Today
    Bankrate, Inc. To Report Fourth Quarter And Full Year 2016 Earnings On March 8, 2017 PR Newswire05:56pm EST
    Why Momenta Pharmaceuticals, Northern Dynasty Minerals, and Unilever Slumped Today at Motley Fool04:45pm EST
    SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Momenta Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm Business Wire04:27pm EST
    Edited Transcript of MNTA earnings conference call or presentation 21-Feb-17 1:00pm GMT Thomson Reuters StreetEvents04:22pm EST
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Momenta Pharmaceuticals, Inc. - MNTA PR Newswire01:37pm EST
    Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today at Motley Fool12:26pm EST
    Momenta Pharma's Supply Partner Gets FDA Warning at Investopedia10:20am EST
    Sarepta Leads Biotech Movers on Voucher Deal News at TheStreet10:09am EST
    NewLink Genetics (NLNK): Moving Average Crossover Alert Zacks10:02am EST
    Momenta beats Street 4Q forecasts AP09:35am EST
    Patterson Companies (PDCO) Q3 Earnings: What's in Store? Zacks08:46am EST
    MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online07:07am EST
    Q4 2016 Momenta Pharmaceuticals Inc Earnings Release - Before Market Open CCBN07:07am EST
    Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results GlobeNewswire07:00am EST
    2:08 am Momenta Pharma receives FDA warning letter for contracted Glatopa - approval of the Glatopa 40mg ANDA will be dependent on resolution of Pfizer (PFE) facility compliance issues Briefing.com02:08am EST
    Monday February 20, 2017
    Forget Alexion, Buy these 4 Biotech Stocks Instead Zacks07:52am EST
    NewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017 GlobeNewswire07:00am EST
    Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS Zacks06:52am EST
    Medtronic (MDT) Q3 Earnings: Disappointment in the Cards? Zacks05:15am EST
    Friday February 17, 2017
    Momenta Pharma shares halted as drug application hits speed bump at MarketWatch06:41pm EST
    Momenta Pharmaceuticals Announces Time Change for Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast GlobeNewswire06:05pm EST
    Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer GlobeNewswire06:00pm EST
    Exelixis Announces Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Metastatic Urothelial Carcinoma and Other Genitourinary Tumors Business Wire05:02pm EST
    Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint? Zacks02:30pm EST
    Easier Regulatory Environment Could Send Biotech Industry Skyrocketing in 2017: Today's Reports on Neuralstem and Exelixis Accesswire09:30am EST